Urology Pathway Board Urology Pathway Board

NCA Urology Pathway Board (NCUPB)

North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration North Region Health & Care Collaboration

Urology Pathway Board

The Pathway Board brings together healthcare professionals, clinical leaders, and multi-agency representatives to enhance patient outcomes, ensure service quality, and promote equitable care across the region.

Urology in the North of Scotland

Urological cancers include those of the bladder, prostate, renal (including kidney), penile and testis. In the past five years, there have been over 7,500 people in the North of Scotland diagnosed with urological cancers.

In the North, investigation and treatment of urological cancers occurs in our three main cancer centres in Aberdeen, Dundee and Inverness. The aim of this Pathway Board is to facilitate regional working between the centres, ensuring a focus on improving patient outcomes.

For more information on the symptoms, investigation and treatment of urological cancers, please visit the NHS Inform website.

Pathway Board details

Clinical Director Andrew Martindale, Consultant Urologist
Terms of Reference Published May 2019

Clinical Management Guidelines (CMGs)

Title Published
Bladder Cancer CMG April 2023
Prostate Cancer CMG April 2023
Prostate Cancer: Bone Health July 2023
Renal Cancer In Development
Testicular Cancer October 2020

Other guidelines

Scottish Cancer Referral Guidelines - Urological Cancers
Scottish Palliative Care Guidelines
Scottish Clinical Biochemistry Guidelines

North of Scotland Quality Performance Indicator (QPI) Annual Reports

Bladder

Bladder Cancer QPI Annual Report (2020-21 patients)
Bladder Cancer QPI Annual Report (2019-20 patients)
Bladder Cancer QPI Annual Report (2018-19 patients)
Bladder Cancer QPI Annual Report (2017-18 patients)
Bladder Cancer QPI Annual Report (2016-17 patients)
Bladder Cancer QPI Annual Report (2015-16 patients)
Bladder Cancer QPI Annual Report (2014-15 patients)

Prostate

Prostate Cancer QPI Annual Report (2021-22 patients)
Prostate Cancer QPI Annual Report (2020-21 patients)
Prostate Cancer QPI Annual Report (2019-20 patients)
Prostate Cancer QPI Annual Report (2018-19 patients)
Prostate Cancer QPI Annual Report (2017-18 patients)
Prostate Cancer QPI Annual Report (2016-17 patients)
Prostate Cancer QPI Annual Report (2015-16 patients)

Renal

Renal Cancer QPI Annual Report (2020 patients)
Renal Cancer QPI Annual Report (2019 patients)
Renal Cancer QPI Annual Report (2018 patients)
Renal Cancer QPI Annual Report (2013 patients)

Testis

Testicular Cancer QPI Annual Report (2021-22 patients)
Testicular Cancer QPI Annual Report (2020-21 patients)
Testicular Cancer QPI Annual Report (2019-20 patients)
Testicular Cancer QPI Annual Report (2018-19 patients)
Testicular Cancer QPI Annual Report (2017-18 patients)
Testicular Cancer QPI Annual Report (2015-16 patients)
Testicular Cancer QPI Annual Report (2014-15 patients)

Quality Performance Indicator (QPI) National Reports

Bladder

Bladder Cancer QPI National Report (2017-20 patients)
Bladder Cancer QPI National Report (2014-17 patients)

Prostate

Prostate Cancer QPI National Report (2018-21 patients)
Prostate Cancer QPI National Report (2012-14 patients)

Renal

Renal Cancer QPI National Report (2018-20 patients)
Renal Cancer QPI National Report (2015-17 patients)
Renal Cancer QPI National Report (2012-14 patients)

Testis

Testicular Cancer QPI National Report (2017-20 patients)
Testicular Cancer QPI National Report (2014-17 patients)